LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...

Simulations Plus, Inc SLP is slated to release second-quarter fiscal 2025 after the closing bell on April 3, 2025. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks ...

Okay. Welcome, everybody. My name is Stan Berenshteyn. I cover digital health of Wells Fargo. With me today is Shawn O'Connor, he's the CEO of Simulations Plus. How are you? Absolutely. We, at ...

Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report fourth quarter and fiscal 2024 financial results after the market ...

Simulations Plus is a software company that develops tools for modeling and simulation in the pharmaceutical, biotechnology, and chemical industries. In June 2024, Simulations Plus acquired ...

(RTTNews) - Simulations Plus, Inc. (SLP) released earnings for its first quarter that Increased from last year but missed the Street estimates. The company's earnings came in at $0.68 million, or ...

NEW YORK CITY, NY / ACCESS Newswire / August 28, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ:SLP) for potential ...

Simulations Plus advised investors that, in June, the Company had initiated a restructuring of its operations, including workforce reductions and cost-cutting measures, aimed at improving operational ...